Preview

Medical Genetics

Advanced search

Whole-genome sequencing of athletes: the effect of nonsense mutations on functional variables

https://doi.org/10.25557/2073-7998.2021.04.19-29

Abstract

The use of whole-genome sequencing technology provides extensive opportunities for the detection of new genetic markers that determine athletic performance. The aim of the study was to characterize the genome profile of high-class athletes and to identify genetic variants associated with some functional variables which can affect sports success. Materials and methods. For the first time, whole-genome sequencing of 20 professional belt wrestlers of Tatar nationality was carried out. Genetic variants were validated using microarray technology and/or imputation procedure. From the entire spectrum of variants those that were annotated as nonsense mutations, were found at the homozygous state and showed association with muscle mass, lower-extremity peak power, reaction time, and sprinting abilities were selected. The mutant allele frequencies of these variants were compared with the frequencies in other populations of the Volga-Ural region. Results. About 11 million polymorphic loci were found in the genomes of wrestlers, an average of 3.62 million single nucleotide polymorphisms and 617 thousand indels per genome. Of these, 347 variants potentially cause premature termination of protein translation. Correlation with sports phenotypes was found for 6 nonsense mutations (ANKDD1B, SLC6A18, CCHCR1, VOPP1, ADAMTS12, and ZACN genes), which in a homozygous state lead to significant changes in functional indicators of athletes. Wrestlers with p.Tyr319* (rs7447815) substitution in the SLC6A18 gene had decreased relative lower-extremity peak power. At the same time, a lower mutant allele frequency at this locus was registered in Tatar wrestlers compared to the Bashkirs and Russians. Also, according to the GWAS, the rs7447815 substitution is associated with the risk of osteoarthritis and decreased physical activity. Conclusions. The number of polymorphic variants found in the genomes of athletes and the proportion of nonsense mutations in them correlate with the results described for other populations. The nonsense mutation p.Tyr319* (rs7447815) in the SLC6A18 gene is a potential marker that reduces the relative peak power of the lower extremities.

About the Authors

E. A. Boulygina
Kazan (Volga region) Federal University
Russian Federation


O. V. Borisov
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn
Russian Federation


E. V. Valeeva
Kazan (Volga region) Federal University
Russian Federation


E. A. Semenova
Kazan (Volga region) Federal University; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Russian Federation


A. K. Larin
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Russian Federation


R. M. Nabiullina
Kazan State Medical University
Russian Federation


F. A. Mavliev
Volga Region State Academy of Physical Culture, Sport and Tourism
Russian Federation


A. M. Akhatov
Volga Region State Academy of Physical Culture, Sport and Tourism
Russian Federation


E. V. Generozov
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Russian Federation


I. I. Ahmetov
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Kazan State Medical University; Plekhanov Russian University of Economics; Research Institute for Sport and Exercise Sciences, Liverpool John Moores University
Russian Federation


References

1. Maciejewska-Skrendo A., Sawczuk M., Cięszczyk P. et al. Genes and power athlete status. In Sports, Exercise, and Nutritional Genomics: Current Status and Future Directions. Academic Press, 2019:41-72.

2. Semenova E.A., Fuku N., Ahmetov I.I. Genetic profile of elite endurance athletes. In Sports, Exercise, and Nutritional Genomics: Current Status and Future Directions. Academic Press, 2019:73-104.

3. Valeeva E.V., Ahmetov I.I., Rees T. Psychogenetics and sport. In Sports, Exercise, and Nutritional Genomics: Current Status and Future Directions. Academic Press, 2019:147-165.

4. Бондарева Э.А., Шиян В.В., Спицын В.А., Година Е.З. Ассоциации четырех полиморфных генетических систем (АСЕ, EPAS1, ACTN3 и NOS3) со спортивной успешностью в борьбе самбо. Вестник Московского университета. Серия 23. Антропология. 2010(1),36-45.

5. Li H., Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-595.

6. Kim S., Scheffler K., Halpern A.L., et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15(8):591-594.

7. Loh P.R., Danecek P., Palamara P.F, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nature Genet. 2016;48(11):1443.

8. Das S., Forer L., Schönherr S., et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48(10):1284-1287.

9. Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.

10. O’Leary N., Wright M., Brister J., et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733-45.

11. Landrum M.J., Lee J.M., Benson M., et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062-D1067.

12. Sherry S.T., Ward M.H., Kholodov M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308-11.

13. Karczewski K.J., Francioli L.C., Tiao G., et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434-443.

14. Thomas P.D., Campbell M.J., Kejariwal A., et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003;13:2129-2141.

15. Boulygina E.A., Lukianova E., Grigoryeva T., et al. Lessons from the whole exome sequencing effort in populations of Russia and Tajikistan. BioNanoScience. 2016:6(4):540-542.

16. Triska P., Chekanov N., Stepanov V., et al. Between Lake Baikal and the Baltic Sea: genomic history of the gateway to Europe. BMC Genet. 2017;18(1):5-20.

17. Carvalho-Silva D., Pierleoni A., Pignatelli M., et al. Open Targets Platform: new developments and updates two years on. Nucleic Acids Res. 2019;47(D1):D1056-D1065.

18. Zhernakova D.V., Brukhin V., Malov S., et al. Genome-wide sequence analyses of ethnic populations across Russia. Genomics. 2020;112(1):442-458.

19. Seidualy M., Blazyte A., Jeon S., et al. Decoding a highly mixed Kazakh genome. Hum Genet. 2020;139(5):557-568.

20. Francioli L.C., Menelaou A., Pulit S.L., et al. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46(8):818.

21. Boulygina E.A., Borisov O.V., Valeeva E.V., et al. Whole genome sequencing of elite athletes. Biol Sport. 2020;37(1):295-304.

22. MacArthur D.G., Balasubramanian S., Frankish A., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335(6070):823-828.

23. Fujikura K. Premature termination codons in modern human genomes. Sci Rep. 2016;6:22468.

24. Yang Y., Zhao H., Boomsma D.I., et al. Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet. 2018;26(8):1202-1216.

25. Matsumoto K., Shimodaira M., Nakagawa T., et al. Association study: SLC6A18 gene and myocardial infarction. Clin Biochem. 2011;44(10-11):789-794.

26. Tiala I., Suomela S., Huuhtanen J., et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med. 2007;85(6):589-601.

27. Brenner L.N., Mercader J.M., Robertson C.C., et al. Analysis of glucocorticoid-related genes reveal CCHCR1 as a new candidate gene for type 2 diabetes. J Endocr Soc. 2020.

28. Bonin F., Taouis K., Azorin P., et al. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX. BMC Biol. 2018;16(1):1-16.

29. Cal S., Argüelles J.M., Fernández P.L., et al. Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J Biol Chem. 2001;276(21):17932-17940.


Review

For citations:


Boulygina E.A., Borisov O.V., Valeeva E.V., Semenova E.A., Larin A.K., Nabiullina R.M., Mavliev F.A., Akhatov A.M., Generozov E.V., Ahmetov I.I. Whole-genome sequencing of athletes: the effect of nonsense mutations on functional variables. Medical Genetics. 2021;20(4):19-29. (In Russ.) https://doi.org/10.25557/2073-7998.2021.04.19-29

Views: 524


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)